RALEIGH, N.C., March 06, 2018 (GLOBE NEWSWIRE) -- Syneos HealthTM (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced that Chief Executive Officer Alistair Macdonald is scheduled to present at the Barclays Global Healthcare Conference in Miami. Mr. Macdonald’s presentation is scheduled for Tuesday, March 13, 2018, at 8:00 a.m. EDT.
Links to Syneos Health’s live presentation and archived audio replay, as well as the presentation materials, will be available via the Company’s Investor Relations website at investor.syneoshealth.com.
About Syneos Health
Syneos Health (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer performance to address modern market realities. Created through the merger of two industry leading companies – INC Research and inVentiv Health – we bring together more than 21,000 clinical and commercial minds with the ability to support customers in more than 110 countries. Together we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients. To learn more about how we are shortening the distance from lab to lifeTM visit syneoshealth.com.
Contacts
Investor Relations:
Ronnie Speight
Vice President, Investor Relations
+1 919 745 2745
Investor.Relations@syneoshealth.com
Press/Media:
Danielle DeForge
Senior Director, External Communications
+1 202 210 5992
danielle.deforge@syneoshealth.com